Gary E. Archer

8.6k citations

80 papers · 6.5k indexed · 2 hit papers · h-index 42

Impact in

Genetics top 0.2%
- Glioma Diagnosis and Treatment
- Virus-based gene therapy research
Immunology top 0.5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction

Papers in ⓘ

Immunology 43
- Immunotherapy and Immune Responses 36
- T-cell and B-cell Immunology 11
- Immune Cell Function and Interaction 9
Oncology 52
- CAR-T cell therapy research 23
- Cancer Immunotherapy and Biomarkers 16
- HER2/EGFR in Cancer Research 8

Co-authors: Darell D. Bigner (51 shared papers)John H. Sampson (65 shared papers)Duane A. Mitchell (29 shared papers)Allan H. Friedman (19 shared papers)Henry S. Friedman (26 shared papers)James E. Herndon (24 shared papers)Amy B. Heimberger (18 shared papers)Roger E. McLendon (22 shared papers)
Journals: Clinical Cancer Research (10 papers)Journal of Clinical Oncology (6 papers)Neurosurgery (5 papers)Proceedings of the National Academy of Sciences (5 papers)Neuro-Oncology (4 papers)
Partner nations: United States Australia Japan

In The Last Decade

Gary E. Archer

79 papers receiving 6.4k citations

Hit Papers

align trajectories log scale

Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients 2015 · 410 citations

Peers

Countries citing papers authored by Gary E. Archer

Since Specialization

Citations

This map shows the geographic impact of Gary E. Archer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary E. Archer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary E. Archer more than expected).

Fields of papers citing papers by Gary E. Archer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary E. Archer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary E. Archer. The network helps show where Gary E. Archer may publish in the future.

Co-authors

The 25 scholars most cited alongside Gary E. Archer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gary E. Archer Line = papers co-authored together Gary E. Archer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 80 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma Journal of Clinical Oncology ·John H. Sampson, Amy B. Heimberger, Gary E. Archer, Kenneth Aldape, Allan H. Friedman, Henry S. Friedman, Mark R. Gilbert, James E. Herndon, Roger E. McLendon, Duane A. Mitchell, David A. Reardon, Raymond Sawaya, Robert J. Schmittling, Weiming Shi, James J. Vredenburgh, Darell D. Bigner Hit paper breakdown →	2010	613
2	Increased Regulatory T-Cell Fraction Amidst a Diminished CD4 Compartment Explains Cellular Immune Defects in Patients with Malignant Glioma Cancer Research ·Peter E. Fecci, Duane A. Mitchell, John F. Whitesides, Weihua Xie, Allan H. Friedman, Gary E. Archer, James E. Herndon, Darell D. Bigner, Glenn Dranoff, John H. Sampson	2006	468
3	Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients Nature ·Duane A. Mitchell, Kristen A. Batich, Michael D. Gunn, Min-Nung Huang, Luis Sánchez-Pérez, Smita K. Nair, Kendra L. Congdon, Elizabeth A. Reap, Gary E. Archer, Annick Desjardins, Allan H. Friedman, Henry S. Friedman, James E. Herndon, April Coan, Roger E. McLendon, David A. Reardon, James J. Vredenburgh, Darell D. Bigner, John H. Sampson Hit paper breakdown →	2015	410
4	Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma. Proceedings of the National Academy of Sciences ·Peter A. Humphrey, Albert J. Wong, Bert Vogelstein, Michael R. Zalutsky, Gregory N. Fuller, Gary E. Archer, H. S. Friedman, Madan M. Kwatra, Sandra H. Bigner, Darell D. Bigner	1990	302
5	Systemic CTLA-4 Blockade Ameliorates Glioma-Induced Changes to the CD4+ T Cell Compartment without Affecting Regulatory T-Cell Function Clinical Cancer Research ·Peter E. Fecci, Hidenobu Ochiai, Duane A. Mitchell, Peter M. Grossi, Alison E. Sweeney, Gary E. Archer, Thomas J. Cummings, James P. Allison, Darell D. Bigner, John H. Sampson	2007	265
6	Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination Clinical Cancer Research ·Kristen A. Batich, Elizabeth A. Reap, Gary E. Archer, Luis Sánchez-Pérez, Smita K. Nair, Robert J. Schmittling, Pam Norberg, Weihua Xie, James E. Herndon, Patrick Healy, Roger E. McLendon, Allan H. Friedman, Henry S. Friedman, Darell D. Bigner, Gordana Vlahovic, Duane A. Mitchell, John H. Sampson	2017	242
7	An epidermal growth factor receptor variant III–targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme Molecular Cancer Therapeutics ·John H. Sampson, Gary E. Archer, Duane A. Mitchell, Amy B. Heimberger, James E. Herndon, Denise Lally-Goss, Sharon McGehee-Norman, Alison Paolino, David A. Reardon, Allan H. Friedman, Henry S. Friedman, Darell D. Bigner	2009	221
8	Mutant epidermal growth factor receptor up-regulates molecular effectors of tumor invasion. PubMed ·Anita Lal, Chad A. Glazer, Holly M. Martinson, Henry S. Friedman, Gary E. Archer, John H. Sampson, Gregory J. Riggins	2002	212
9	Poor drug distribution as a possible explanation for the results of the PRECISE trial Journal of neurosurgery ·John H. Sampson, Gary E. Archer, Christoph Pedain, Eva Wembacher-Schröder, Manfred Westphal, Sandeep Kunwar, Michael A. Vogelbaum, April Coan, James E. Herndon, Raghu Raghavan, Martin Brady, Davi D.A. Reardon, Allan H. Friedman, Henry S. Friedman, María Inmaculada Rodríguez-Ponce, Susan M. Chang, Stephan Mittermeyer, Davi Croteau, Raj K. Puri, James M. Markert	2009	198
10	Epidermal growth factor receptor VIII peptide vaccination is efficacious against established intracerebral tumors. PubMed ·Amy B. Heimberger, Laura E. Crotty Alexander, Gary E. Archer, Kenneth R. Hess, Carol J. Wikstrand, Allan H. Friedman, Henry S. Friedman, Darell D. Bigner, John H. Sampson	2003	193
11	Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system. Proceedings of the National Academy of Sciences ·John H. Sampson, Gary E. Archer, David M. Ashley, Herbert E. Fuchs, Laura P. Hale, Glenn Dranoff, Darell D. Bigner	1996	183
12	Unarmed, tumor-specific monoclonal antibody effectively treats brain tumors Proceedings of the National Academy of Sciences ·John H. Sampson, Laura E. Crotty Alexander, Samson Lee, Gary E. Archer, David M. Ashley, Carol J. Wikstrand, Laura P. Hale, Clayton Small, Glenn Dranoff, Allan H. Friedman, Henry S. Friedman, Darell D. Bigner	2000	150
13	The class III variant of the epidermal growth factor receptor (EGFRvIII): characterization and utilization as an immunotherapeutic target Journal of NeuroVirology ·Carol J. Wikstrand, Craig J. Reist, Gary E. Archer, Michael R. Zalutsky, Darell D. Bigner	1998	141
14	Brain tumors in mice are susceptible to blockade of epidermal growth factor receptor (EGFR) with the oral, specific, EGFR-tyrosine kinase inhibitor ZD1839 (iressa). PubMed ·Amy B. Heimberger, Chris A. Learn, Gary E. Archer, Roger E. McLendon, Tracy A. Chewning, Frank L. Tuck, J.B. Pracyk, Allan H. Friedman, Henry S. Friedman, Darell D. Bigner, John H. Sampson	2002	138
15	Resistance to Tyrosine Kinase Inhibition by Mutant Epidermal Growth Factor Receptor Variant III Contributes to the Neoplastic Phenotype of Glioblastoma Multiforme Clinical Cancer Research ·Chris A. Learn, Tristan L. Hartzell, Carol J. Wikstrand, Gary E. Archer, Jeremy N. Rich, Allan H. Friedman, Henry S. Friedman, Darell D. Bigner, John H. Sampson	2004	131
16	Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant glioma Seminars in Immunology ·John H. Sampson, Gary E. Archer, Duane A. Mitchell, Amy B. Heimberger, Darell D. Bigner	2008	128
17	Bone marrow-derived dendritic cells pulsed with tumor homogenate induce immunity against syngeneic intracerebral glioma Journal of Neuroimmunology ·Amy B. Heimberger, Laura E. Crotty Alexander, Gary E. Archer, Roger E. McLendon, Allan H. Friedman, Glenn Dranoff, Darell D. Bigner, John H. Sampson	2000	111
18	Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral glioma Proceedings of the National Academy of Sciences ·Bryan D. Choi, Chien‐Tsun Kuan, Mingqing Cai, Gary E. Archer, Duane A. Mitchell, Patrick C. Gedeon, Luis Sánchez-Pérez, Ira Pastan, Darell D. Bigner, John H. Sampson	2012	111
19	EGFRvIII‐Targeted Vaccination Therapy of Malignant Glioma Brain Pathology ·Bryan D. Choi, Gary E. Archer, Duane A. Mitchell, Amy B. Heimberger, Roger E. McLendon, Darell D. Bigner, John H. Sampson	2009	107
20	A Novel Inhibitor of Signal Transducers And Activators Of Transcription 3 Activation Is Efficacious Against Established Central Nervous System Melanoma and Inhibits Regulatory T Cells Clinical Cancer Research ·Ling-Yuan Kong, Mohamed Abou-Ghazal, Jun Wei, Arup Chakraborty, Wei Sun, Wei Qiao, Gregory N. Fuller, Izabela Fokt, Elizabeth A. Grimm, Robert J. Schmittling, Gary E. Archer, John H. Sampson, Waldemar Priebe, Amy B. Heimberger	2008	107

About Gary E. Archer

Gary E. Archer is a scholar working on Immunology, Oncology, Genetics, Radiology, Nuclear Medicine and Imaging and Immunology and Allergy, having authored 80 papers that have together received 6.5k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (36 papers), CAR-T cell therapy research (23 papers), Cancer Immunotherapy and Biomarkers (16 papers), Monoclonal and Polyclonal Antibodies Research (16 papers), Glioma Diagnosis and Treatment (14 papers), T-cell and B-cell Immunology (11 papers), Immune Cell Function and Interaction (9 papers) and HER2/EGFR in Cancer Research (8 papers). The work is most often cited by research in Genetics (2.4k citations), Immunology (3.2k citations), Oncology (3.7k citations), Radiology, Nuclear Medicine and Imaging (923 citations) and Cancer Research (484 citations). Gary E. Archer has collaborated with scholars based in United States, Australia and Japan. Frequent co-authors include Darell D. Bigner, John H. Sampson, Duane A. Mitchell, Allan H. Friedman, Henry S. Friedman, James E. Herndon, Amy B. Heimberger, Roger E. McLendon, Michael R. Zalutsky and Glenn Dranoff. Their work appears in journals such as Clinical Cancer Research, Journal of Clinical Oncology, Neurosurgery, Proceedings of the National Academy of Sciences and Neuro-Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact